Finance

Lists
605199:SHA
Hainan Huluwa Pharmaceutical Grop Co Ltd
CN¥5,59
+0,54%
(+0,030) 1D
16 Okt., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605199...
Open
CN¥5,56
High
CN¥5,66
Low
CN¥5,55
Mkt. cap
2,28 mjd
Avg. vol.
895,31 k
Volume
571,60 k
52-wk high
CN¥10,37
52-wk low
CN¥5,15
EPS
-CN¥1,01
No. of employees
1 k
Open
CN¥5,56
High
CN¥5,66
Low
CN¥5,55
Mkt. cap
2,28 mjd
Avg. vol.
895,31 k
Volume
571,60 k
52-wk high
CN¥10,37
52-wk low
CN¥5,15
EPS
-CN¥1,01
No. of employees
1 k
News stories
From web sources and news partners
About Hainan Huluwa Pharmaceutical Grop Co Ltd
CEO-
Employees1,45 k
Founded22 Jun. 2005
Headquarters-
SectorPharmaceutical industry
Websitehuluwayaoye.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
175,05 m
218,12 m
146,14 m
94,74 m
Cost of goods sold
109,36 m
249,53 m
109,42 m
113,10 m
Cost of revenue
109,36 m
249,53 m
109,42 m
113,10 m
Research and development expenses
946,68 k
73,54 m
6,36 m
4,58 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
66,76 m
122,38 m
44,56 m
50,47 m
Operating expense
39,98 m
246,00 m
48,45 m
64,89 m
Total operating expenses
149,33 m
495,53 m
157,87 m
178,00 m
Operating income
25,72 m
-277,41 m
-11,74 m
-83,26 m
Other non operating income
1,26 m
-1,31 m
-41,63 k
-2,12 m
EBT including unusual items
-11,40 m
-265,45 m
-28,10 m
-84,16 m
EBT excluding unusual items
17,79 m
-289,30 m
-20,47 m
-93,38 m
Income tax expense
666,12 k
11,33 m
310,34 k
-604,95 k
Effective tax rate
-5,84%
-4,27%
-1,10%
0,72%
Other operating expenses
-30,88 m
35,66 m
-3,28 m
8,81 m
Net income
-13,62 m
-276,16 m
-28,96 m
-84,43 m
Net profit margin
-7,78%
-126,61%
-19,82%
-89,12%
Earnings per share
-
-
-
-
Interest and investment income
79,70 k
133,90 k
201,59 k
35,40 k
Interest expense
-9,27 m
-10,71 m
-8,89 m
-8,03 m
Net interest expenses
-9,19 m
-10,57 m
-8,69 m
-8,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
44,06 m
-253,42 m
12,26 m
-58,36 m
Gain or loss from assets sale
-323,74 k
53,83 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme